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Abstract 
 
Objective. Retinal prostheses aim to restore sight by electrically stimulating the surviving retinal neurons. 
In clinical trials of the current retinal implants, prosthetic visual acuity does not exceed 20/550. However, to 
provide meaningful restoration of central vision in patients blinded by age-related macular degeneration (AMD), 
prosthetic acuity should be at least 20/200, necessitating a pixel pitch of about 50 µm or lower. With such small 
pixels, stimulation thresholds are high due to limited penetration of electric field into tissue. Here, we address this 
challenge with our latest photovoltaic arrays and evaluate their performance in-vivo.  
Approach. We fabricated photovoltaic arrays with 55 and 40 µm pixels (a) in flat geometry, and (b) with 
active electrodes on 10 µm tall pillars. The arrays were implanted subretinally into rats with degenerate retina. 
Stimulation thresholds and grating acuity were evaluated using measurements of the visually evoked potentials 
(VEP).  
Main Results. With 55 m pixels, we measured grating acuity of 48±11 μm, which matches the linear pixel 
pitch of the hexagonal array. This geometrically corresponds to a visual acuity of 20/192 in a human eye, matching 
the threshold of legal blindness in the US (20/200). With pillar electrodes, the irradiance threshold was nearly 
halved, and duration threshold reduced by more than 3-fold, compared to flat pixels. With 40 m pixels, VEP was 
too low for reliable measurements of the grating acuity, even with pillar electrodes.  
Significance. While being helpful for treating a complete loss of sight, current prosthetic technologies are 
insufficient for addressing the leading cause of untreatable visual impairment - AMD. Subretinal photovoltaic 
arrays may provide sufficient visual acuity for restoration of central vision in patients blinded by AMD. 
  
 
Introduction 
Age-related macular degeneration (AMD) is a leading cause of untreatable vision loss, affecting over 8.7% 
of the population worldwide(1). Advanced forms of AMD (neovascularization and geographic atrophy) are 
associated with severe visual impairment, and their prevalence dramatically increases with age: from 1.5% in US 
population above 40 years to more than 15% in population older than 80 years(2). Despite losing high-resolution 
central vision, these patients rarely exhibit visual acuity worse than 20/400 due to preservation of peripheral 
vision. Therefore, prosthetic restoration of sight in such conditions may only be beneficial if acuity reaches 20/200 
or better.  
In the healthy retina, photoreceptors convert light into electrical and chemical signals, which propagate 
to bipolar cells located in the inner nuclear layer (INL), and then to retinal ganglion cells (RGC), which generate 
trains of action potentials transmitted to the brain via the optic nerve. In retinal degenerative diseases, gradual 
loss of photoreceptors leads to visual impairment, while the remaining retinal neurons survive to a large extent(3-
5).  
Electronic retinal prostheses are designed to reintroduce visual information into the degenerate retina by 
electrical stimulation of the surviving inner retinal neurons. Current strategies involve placing electrode arrays 
either subretinally, to stimulate the first neural layer after photoreceptors (mainly bipolar cells in the INL)(6-8), or 
epiretinally, to target the output layer (RGCs)(9, 10).  
Direct stimulation of RGCs with epiretinal implants bypasses the retinal network. With one action 
potential elicited by one stimulation pulse, theoretically, this approach may induce spike trains which reproduce 
the natural retinal code in each of the two dozen types of ganglion cells, if they could be identified and selectively 
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stimulated(11). However, the epiretinal implant currently approved for human use (ARGUS II, Second Sight Inc., 
Sylmar, California, USA) has electrodes much larger than cellular size (200 m in diameter, 575 m pitch)(12), 
which are relatively far (on average ~180 m) from the target cells(13) and result in indiscriminate activation of 
multiple cell types. Consequently, patients with this system reported extremely low visual acuity – no better than 
20/1260 (14). Moreover, epiretinal stimulation elicited responses not only from the underlying neurons, but also 
the bypassing axons from remote RGCs, causing distorted visual percepts(15).  
On the other hand, bipolar cells can be modulated gradually, by amplitude or duration of the stimulus(16). 
The elicited neural signals are then transmitted via retinal network to the ganglion cells, which respond with bursts 
of spikes.  Such a network-mediated response of degenerate retina preserves many features of normal vision, 
including flicker fusion at high frequencies (>20Hz)(17, 18), adaptation to static images(19), and antagonistic 
center-surround organization of receptive fields, as demonstrated with RCS rats(20).   
In clinical trials of a subretinal implant (Alpha IMS/AMS, Retinal Implant AG, Reutlingen, Germany), visual 
acuity was typically below 20/1200, with two exceptional patients reaching 20/546(21, 22). This implant has 1500 
to 1600 pixels, each 70 m in size. Since the theoretical limit of resolution with this array is about 20/280, it is 
alarming that none of the patients achieved such levels of acuity. One reason could be due to the monopolar 
design of this implant, where active electrodes in each pixel share a common remote return electrode. This results 
in strong cross-talk between the neighboring electrodes, leading to greatly reduced spatial contrast(23).   
To reduce the cross-talk, we have improved the localization of electric field to the level required for higher 
visual acuity by developing a photovoltaic subretinal prosthesis with active and return electrodes in each pixel. 
Photodiodes convert pulsed light projected from augmented reality glasses(24) into electric current that flows 
through the tissue between two electrodes in each pixel, stimulating the nearby inner retinal neurons - mostly 
bipolar cells(25, 26). To avoid visual perception of bright light by remaining photoreceptors, we use near-infrared 
(NIR, 880-915 nm) wavelengths. Direct photovoltaic conversion of light into electric current eliminates the need 
for power supply and cables, which greatly simplifies surgical procedures and reduces associated postoperative 
complications(27).  
Previously, we demonstrated that implants with 75 μm pixels provided grating acuity matching the pixel 
pitch in rats(18). Here, we show that subretinal pixels can be miniaturized further, while still eliciting retinal 
response well within the safety limits. Grating acuity with these arrays matches the pixel pitch below 50 m, 
corresponding to the threshold of legal blindness (20/200) in the US.  
One of the major problems with reducing the size of bipolar pixels is that this miniaturization decreases 
penetration depth of electric field into tissue (Figure 1). Also, smaller electrodes have lower charge injection 
capabilities. To deliver electric field closer to the target cells, we fabricated devices with active electrodes elevated 
on top of pillars(28). After implantation, cells of the INL migrated into the space between the pillars, improving 
the proximity of 3-dimensional electrodes to neurons, which led to reduction in stimulation thresholds. Not only 
does this enable safer activation of cells, but it also widens the dynamic range of prosthetic vision for better 
encoding of the visual information. 
 
Methods 
 
Implant fabrication 
The photovoltaic arrays were designed based on the fabrication and operation principles published earlier 
(28, 29) , using an updated fabrication process and smaller pixel sizes. Implants of 1 mm in diameter and 30 m in 
thickness consist of hexagonally arranged photovoltaic pixels (Figure 2). In a rat eye, these implants cover 
approximately 20 degrees of the visual field (30). In the current study, pixels were either 40 or 55 m in width, 
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corresponding to 502 or 250 pixels in each array, respectively. Due to the hexagonal arrangement, spacing of the 
adjacent rows, i.e. pixel pitch, is 35 and 48 m, respectively. Each pixel includes two diodes connected in series 
between the active (A) and return electrode (B) (Figure 2) to maximize the efficiency of subretinal charge injection 
and stimulation(31). The diodes are fabricated on n- silicon substrate (phosphorus 1015 cm-3) with p+ doping 
(boron 1019 cm-3) and a junction depth of 1.5 m. Active electrodes are connected to the p+ regions, so that they 
develop a positive potential with respect to return electrode when the device is illuminated. To increase the 
photosensitive area compared to previous design(18), we minimized the width of the isolation trenches between 
diodes and between pixels to 1 m. We also eliminated the 5 m-wide open trenches between pixels, which were 
helpful in the previous implants for diffusion of oxygen and nutrients in ex-vivo experiments but are not required 
in-vivo due to presence of the retinal vasculature. Return electrodes connected across the entire array are shared 
across the pixel boundaries, and thereby cover the isolation trenches between pixels. Active electrodes are 10 and 
14 m in diameter, and the width of the shared return electrode is 6 and 9 m for 40 and 55 m pixels, respectively 
(i.e. 3 and 4.5 m per pixel), so that the area of the returns is about five times that of the active electrodes (Figure 
2b).  Active and return electrodes were coated with sputtered iridium oxide film (SIROF) to create a high-
capacitance electrode-electrolyte interface. To prevent the implant erosion and provide an antireflection coating, 
all implants were covered with 380 nm of amorphous silicon carbide (SiC) on top of 70 nm of silicon dioxide (SiO2), 
optimized for 880 nm illumination (32). 
Pillars were electroplated with gold on top of the photovoltaic pixels to a height of 10 m, with 
hemispherical caps extending to 10 and 14 m in diameter for 40 and 55 m pixels, respectively (Figure 2d). 
Current density in steady state is proportional to capacitance per unit area(33).  Since the SIROF capacitance is 
about 100 times higher than that of gold (1 mF/cm2 vs. 0.01 mF/cm2)(31, 34), and the area of a gold pillar is similar 
to that of the SIROF cap, current flows predominantly through the SIROF-coated cap, even though the pillar 
sidewalls are not insulated. Electroplating was performed through a patterned photoresist mold(28) using a 
sacrificial aluminum (Al) layer to connect the active electrodes to the current source.  
For the rest of this paper, we will use the following nomenclature: F55 and F40 for flat arrays with 55 and 
40 μm pixels, respectively, and Pil55 and Pil40 for arrays with pillar electrodes of the same pixel sizes. 
 
Animals and implantation 
Royal College of Surgeons (RCS) rats were used as an animal model of inherited retinal degeneration. In 
these animals, a mutation in the MERTK gene reduces the phagocytic capability of the retinal pigmented 
epithelium (RPE), leading to degeneration of photoreceptors by 4 months(35). Rats were implanted after the loss 
of photoreceptors, and the follow-up continued for the life of the animals (up to one year).  The animals were 
housed and maintained at the Stanford animal facility with a 12 hr light/12 hr dark cycle with food and water ad 
libitum. Adult Long-Evans WT rats were purchased from Charles River Laboratories (Wilmington, MA, USA) as a 
wild-type control for measurements of the grating acuity (n=6) and frequency response (n=5). All in-vivo 
experimental procedures were conducted in accordance with the Stanford University institutional guidelines and 
conformed to the guidelines of the Association for Research in Vision and Ophthalmology (ARVO) Statement for 
the Use of Animals in Ophthalmic and Vision research. 
Total of 20 animals were implanted with F55 (n=5), Pil55 (n=5), F40 (n=5), and Pil40 (n=5). The subretinal 
implantation technique was similar to the one previously reported by our group(18). Animals were anaesthetized 
with a cocktail of ketamine (75 mg/kg) and xylazine (5 mg/kg) injected either intraperitoneally or intramuscularly. 
A 1.5 mm incision was made through the sclera and choroid 1.5 mm posterior to the limbus, and the retina was 
lifted with an injection of saline solution. For pillar arrays, a viscoelastic solution (Viscoat, sodium chondroitin 
sulfate 4%-sodium hyaluronate 3%) was dropped on top of the implant to prevent pillars from catching onto the 
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retina during insertion. Upon insertion of the array into the subretinal space, the sclera and conjunctiva were 
sutured with nylon 10-0, and topical antibiotic (Bacitracin/Polymyxin B) applied on the eye postoperatively. 
Surgical success and retinal reattachment were verified using optical coherence tomography (OCT) (HRA2- 
Spectralis; Heidelberg Engineering, Heidelberg, Germany) immediately after surgery. The retina detached during 
surgery settled onto flat implants within a week post-surgery, similarly to our previous studies with larger 
pixels(18). Based on our previous anatomical studies with pillar arrays(28), we allowed six weeks post implantation 
for pillar integration with the retina. We inspected implant stability with OCT again before VEP measurements. All 
implants remained stable in the subretinal space throughout the follow-up period, lasting up to a year.  
 Three transcranial screw electrodes (00 x ¼” stainless steel, part FF00CE250; Morris, Southbridge, MA, 
USA) were implanted and secured in place with cyanoacrylate glue and dental acrylic. The electrodes penetrate 
only the skull but not the brain tissue. One electrode was placed at each hemisphere of the V1 visual cortex (4 
mm lateral from midline, 6 mm caudal to bregma), and a reference electrode was placed 2 mm right of midline 
and 2 mm anterior to bregma. Nose and tail needle electrodes served as a reference and ground, respectively 
(Supp. Figure 1b). 
Retinal stimulation 
 Rats were anesthetized with a cocktail of ketamine (37.5 mg/kg) and xylazine (2.5 mg/kg) injected 
intramuscularly. Steady anesthesia was maintained using the following measures: periodic monitoring of 
spontaneous eye movements and respiratory patters; supplementary injection of half the initial dose every 40 
mins, or as needed. 
Near-infrared (NIR, 915 nm) and green (532 nm) lasers from single-mode fibers were collimated and 
patterned using a digital micromirror display (DMD; DLP Light Commander; LOGIC PD, Carlsbad, CA, USA).  The 
optical system was mounted on a slit lamp (Zeiss SL-120; Carl Zeiss, Thornwood, NY, USA) to allow direct 
observation of the patterns on the retina with a NIR-sensitive CCD camera (acA1300-60gmNIR; Basler, Ahrensburg, 
Germany) (Supp. Figure 1a). Following pupil dilation (and ocular retraction in some cases), the cornea was covered 
with a viscoelastic gel and a cover slip to cancel the optical power of the eye and ensure good retinal visibility. The 
posture of the animal was adjusted to ensure normal beam incidence on the implant center. For full-field 
measurements, NIR stimulation was applied with pulse durations ranging from 0.06 to 10 ms, peak irradiances 
from 0.06 to 8 mW/mm2, and frequencies from 2 to 64 Hz. Linear grating patterns, ranging from 10 to 240 μm per 
stripe, were generated with a custom software. Gratings were alternated (contrast reversal) at 1 Hz, while the 
light sources were pulsed at 40 Hz using 4 ms flashes at 8 mW/mm2 and 100 nW/mm2 for 915 nm and 532 nm 
wavelengths, respectively. Stimulation parameters are listed in Table 1. As a control, we applied NIR pulses (2Hz, 
10ms) at 8mW/mm2 on a 1x1 mm2 area outside the implant to ensure that there was no photoreceptor-mediated 
response. 
 Irradiance (mW/mm2) Pulse duration (ms) Repetition rate (Hz) 
Irradiance threshold 0.125-8 10 2 
Pulse duration threshold 8 0.03-10 2 
Frequency variation 8 4 2-64 
Table 1. Ranges of the stimulation parameters in various measurements. 
Visually-evoked potentials (VEP) recording and analysis 
Visually-evoked potentials (VEP) were recorded using the Espion E2 system (Diagnosys, Lowell, MA, USA) 
at 1 kHz sampling rate using a 0.5-500 Hz bandpass filter and averaged over 500 trials for each experiment. The 
VEP amplitude was quantified as the peak-to-peak voltage of the signal within 350 ms post stimulus.  A detectable 
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VEP response was defined as a deviation from the baseline by more than 6 times the noise level, determined as 
RMS (s.d.) of the signal during 50 ms preceding the stimulus, similar to our previous studies with larger pixels (18). 
In addition, we applied an unpaired t-test to compare the VEP amplitude at a given stimulus parameter to that at 
the noise level in the population of test animals. Modulation of the VEP amplitude by light intensity (with 10 ms 
pulses) and by pulse duration (at 8 mW/mm2) was plotted normalized to the noise amplitude in each animal 
(example traces in Supp. Figure 1c). All electrophysiological measurements were conducted during the months 1-
12 post implantation.  
 
Visual acuity measurements 
 Visual acuity was assessed by recording the cortical response to alternating gratings of various spatial 
frequencies, as described previously(18, 36). For natural acuity measurements, WT rats (n=6) were shown gratings 
with the stripe width ranging from 10 to 240 μm, delivered at 1 Hz reversal rate and 40 Hz carrier frequency. For 
accurate assessment of the noise level, we applied a 40 Hz notch filter to remove oscillations due to the flicker, 
which are more pronounced at high spatial frequencies. The VEP amplitude was defined as the peak-to-peak 
voltage of the cortical signal during the first 350 ms post stimulus. For NIR stimulation, stripe widths varied from 
20 to 240 μm (n=5). For various grating sizes, VEP amplitude was normalized to the maximum in each animal, and 
the noise level was defined as the amplitude at the smallest grating size (example traces in Supp. Figure 1d). To 
define the acuity, the averaged VEP amplitude was plotted as a function of the stripe width and fit with a 2nd-
degree polynomial function using the 20, 40, 60, 80 μm data points for visible light and the 50, 55, 60, 80, 120 μm 
data points for prosthetic stimulation. The visual acuity limit was defined as the intersection point of the fitted 
curve with the noise level. We also tried curve fitting with polynomials of other degrees and including different 
data points, which resulted in lower estimates for the smallest resolvable gratings, i.e. higher grating acuity. The 
chosen fit yielded the most conservative estimate.  
 
Results 
Stimulation Thresholds 
Response to prosthetic stimulation was evaluated by recording VEP via transcranial electrodes placed 
above the visual cortex, as described previously(18, 26) and exemplified in Figure 3a. A near-infrared beam (915 
nm) reflected off the digital micromirror display (DMD), was projected onto the implant from a slit lamp. 
Stimulation thresholds with respect to irradiance and pulse duration, as well as variation of the VEP amplitude 
with frequency, were measured in the ranges summarized in Table 1 (see Methods). The VEP amplitude was 
quantified as the peak-to-peak voltage of the recording within 350 ms post stimulus, and an amplitude greater 
than 6 times the RMS noise was considered a signal above threshold. Previous experiments demonstrated that 
VEP is not present when conduction along the optic nerve is blocked(26). We also verified that RCS rats do not 
respond to NIR flashes projected outside the implant. 
F55 implants (n=5) induced cortical response above 1.0±0.27 mW/mm2 (s.e.m.), while with Pil55 implants 
(n=5) the threshold was 0.55±0.15 mW/mm2 (Figure 3b). The 45% decrease in stimulation threshold agrees with 
our previous modeling results(28). With increasing irradiance, the cortical response with flat implants maintained 
generally the same shape (Figure 3a), while its amplitude increased with irradiance (Figure 3b and Supp. Figure 2). 
Signals with pillar implants had a distinctly different shape: in addition to a short-latency negative peak at ~20 ms 
(double-headed arrow in Figure 3a), there was a second negative peak at ~40 ms and a positive peak about 100 
to 200 ms later. The threshold of the second negative peak (purple arrow) was approximately an order of 
magnitude higher than that of the first negative peak.  
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 The effect of pillars was much more pronounced on the threshold pulse duration: it decreased by 78% - 
from 0.29±0.11 ms (s.e.m.) for F55 implants to 0.08±0.02 ms for Pil55 arrays (Figure 3c). The VEP of flat implants 
maintained the same shape as pulse duration varied, so that only the short (~20 ms) negative wave was detectable 
near the threshold. However, with pillars, the negative peak at 20 ms disappeared for very short pulses (<0.25 
ms), while the much later positive component remained prominent (Figure 3a green arrow).  
Previous studies demonstrated that in healthy retina responding to pulsed visible light ex-vivo, flicker 
fusion occurs at lower frequencies than in degenerate retina responding to prosthetic stimulation with 70m 
pixels(18). Our current measurements in-vivo confirmed this effect for 55 m flat implants, with the normalized 
VEP amplitude of prosthetic vision at 20 Hz being about twice that of natural, and reaching the same level beyond 
50 Hz (Figure 3d). Slower decline of retinal response with increasing frequency in prosthetic vision is likely due to 
absence of photoreceptors, the photochemical processes of which are much slower than the rest of the retinal 
network. However, with all pillar arrays and with 40 m flat pixels, retinal response declined with frequency as 
fast as that of natural vision, suggesting another potential difference in the retinal stimulation mechanisms. 
With F40 arrays (n=5), the thresholds were significantly higher (1.8±0.58 mW/mm2 and 0.83±0.17 ms) and 
the maximum VEP amplitude about twice lower than that with 55 m pixels (Figure 3b). Even though the threshold 
is below the ocular safety limit (5 mW/mm2 average irradiance at 880 nm(37)), not much range remains for 
encoding grey levels and assessing grating acuity, which requires a good signal-to-noise ratio achieved at 
irradiance levels far above the stimulation threshold. Pil40 arrays (n=5) had thresholds of 1.3±0.27 mW/mm2 and 
0.7±0.12 ms, but this improvement did not result in increase of the maximum VEP amplitude – it was still only half 
that with 55 m pixels. The effect of pillars on pulse duration with 40 m pixels was also much smaller than with 
55 m. 
Implant Type F55 Pil55 F40 Pil40 
Irradiance threshold (mW/mm2) 1.0±0.27 0.55±0.15 1.8±0.58 1.3±0.27 
Duration threshold (ms) 0.29±0.11 0.08±0.02 0.83±0.17 0.7±0.12 
Table 2. Stimulation thresholds with 4 types of implants. All errors are listed in terms of s.e.m. 
Grating Acuity 
Measuring the cortical response to alternating gratings is an established method to assess visual acuity in 
animals(36) and in human infants(38, 39). Visual acuity measured with this method matches that of behavioral 
tests(40). We recorded the VEP response to alternating grating patterns projected onto the implant with 55μm 
pixels in RCS rats. Images were delivered with NIR light at 8 mW/mm2 peak irradiance using 4 ms pulses at 40 Hz 
repetition rate, and pattern reversal at 1 Hz. The resulting VEP waveforms contained both a 2 Hz (pattern reversal-
induced) and 40 Hz (pulse-induced) component. Using a 40-Hz notch filter, we singled out the pattern reversal-
induced response (Figure 4a), with its amplitude measured as the peak-to-peak voltage between 0 and 100 ms 
after each pattern reversal. As a control, the same experiment was performed on healthy rats (Long Evans, n=6) 
using green light (532 nm) illumination pulsed at 40 Hz.  
The grating acuity limit was assessed by extrapolating the measured data down to noise level(18) (see 
Methods). Smaller grating width corresponds to better grating acuity. As can be seen in Figure 4b, for prosthetic 
vision with 55 m pixels, this limit corresponds to 48±11 μm (s.e.m.). In a hexagonal array, adjacent rows are 
separated by w=d·cos(30o) = 𝑑√3/2 = 0.87d, where d is the pixel width. For d=55 m, the distance between 
adjacent rows of pixels is w=48 m, matching the measured acuity. For natural vision, the measured grating acuity 
limit is 17±5 μm. With 40 m pixels, even having pillar electrodes, the VEP amplitude was too low for a reliable 
measurement of the grating acuity.  
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In measurements of the grating acuity, there is a concern whether the detected VEP response resulted 
from aliasing or truly resolving the grating. According to the Nyquist sampling theory, spatial resolution (minimum 
stripe width of the grating) of the sensor array with a pixel size d, is limited by the row pitch, which for a hexagonal 
array is 0.87d. To assess the extent of aliasing, we simulated the pixel activation pattern when a grating image is 
projected onto a hexagonal array. As shown in Supplemental Figure 3, for grating widths larger than 0.8d, the 
pixelated image matches the original pattern. As the bar width decreased to approximately 0.7d, the orientation 
of the pixelated image became ambiguous. With 55 m pixels, 0.7d = 38.5 m. As can be seen in Figure 4, 
prosthetic VEP in our measurements did not drop to the noise level at 40 m, indicating that aliasing may be 
involved in this response.  To avoid any potential effect of aliasing on assessment of the grating acuity, we did not 
include any data points below the sampling density limit into the extrapolation dataset.  
 
Discussion 
Our results demonstrate that hexagonal photovoltaic arrays with 55 μm pixels provide a grating acuity 
matching the minimum distance between adjacent rows, i.e., the Nyquist sampling limit of 48 μm. Depending on 
the orientation of the grating, visual acuity with such arrays ranges from 20/192 to 20/220 in a human eye. If 
successful in human trials, prosthetic vision with such spatial resolution should benefit not only the patients 
blinded completely by inherited retinal degeneration (such as Retinitis Pigmentosa), but also much more patients 
with central vision loss due to advanced AMD.   
Although the retinal circuitry undergoes drastic remodeling during the end-stage of degeneration, when 
all photoreceptors are lost, as in Retinitis Pigmentosa (41, 42), recent clinical trials have demonstrated shape 
perception with subretinal electrical stimulation in RP patients (22). In AMD patients, photoreceptors are lost only 
within a few-mm-wide zone in the central macula, and the inner retinal structure is much better preserved in 
these areas, compared to the end-stage of RP. Therefore, restoration of central vision in AMD patients with 
subretinal implants might provide even better results, as evidenced by the recent success of the PRIMA 
implant(43). However, retinal degeneration may still limit the attainable visual acuity, and this effect remains to 
be tested with high resolution implants in clinical trials.  
Stimulation threshold of subretinal implants increases with decreasing size d of bipolar pixels 
approximately as 1/d2: from 0.13 to 0.55, 1.0, and 1.8 mW/mm2 with pixels of 140, 70, 55, and 40 m in size(17, 
18). This is largely due to the fact that the electric field penetrates into the tissue by approximately half a pixel 
width. Pillar electrodes improve proximity to target neurons, and therefore can reduce the stimulation threshold 
to some extent. However, they do not allow a very significant decrease in pixel size since this design is still limited 
by the geometry of spherical expansion of electric field.  
Surprisingly, pillar electrodes affected the shape of the visually evoked potential and its dependence on 
pulse duration. In particular, pillars reduced the pulse duration threshold more than 3-fold, when compared to 
flat arrays. Since the ocular safety limit is set primarily by cumulative heating (37), reduced pulse duration helps 
in this regard nearly as much as reduced irradiance.  
However, with 40 m pixels, not only was the stimulation threshold nearly tripled, but also the maximum 
VEP response was halved, when compared with 55 m arrays. Even with pillar electrodes, the SNR was too low 
for acuity measurements, and we could not take full advantage of the reduced pulse duration threshold by 
increasing the pulse amplitude due to limited peak brightness of the beam.  Therefore, other geometries should 
be explored for improving stimulation efficacy and further reduction (beyond 40 m) of the pixel size(44, 45).  
Currently, it is not clear why the shape of the VEP signal elicited by pillar electrodes is different compared 
to planar implants, or why it changes with irradiance and with pulse duration.  It could be due to some 
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discrimination between the cell types residing at different depths of the INL(46) or due to heterogeneous 
distribution of ion channels(47), which play a more prominent role in non-monotonic fields(16). It will be 
interesting to see whether these differences will affect the visual percepts in clinical testing.   
 
In conclusion, in rats with retinal degeneration, hexagonal arrays with 55 μm pixels provide grating acuity 
matching the row spacing of 48 m, which in a human eye geometrically corresponds to visual acuity matching 
the threshold of legal blindness (20/200). If successful in clinical testing, such arrays could provide highly functional 
prosthetic vision even for patients with the loss of only central vision, as in AMD. Scaling the pixel size further 
down is difficult even with pillar electrodes since stimulation thresholds approach the ocular safety limit and the 
cortical signal becomes too weak for electrophysiological measurements. 
 
Figure Captions 
Figure 1. Illustration of electric potential with 55 m-pixel implants using a previously described model (28), 
plotted over a histological image of the rat retina. (a) With flat pixels, the top cells in the inner nuclear layer (INL) 
are not stimulated. (b) By elevating the active electrode (1) halfway into the INL, electric field can penetrate 
deeper into the INL. Return electrode (2) remains on the surface of the device. 
Figure 2. Scanning electron micrographs (SEM) of the hexagonal photovoltaic arrays with 55 μm pixels. (a) The 
whole implant of 1 mm in width, containing 250 pixels. The array was placed on top of the retinal pigmented 
epithelium for scale. (b) Higher magnification of the implant demonstrates relative sizes of the central active 
electrode (1) and circumferential return electrode (2) in flat pixels. The active electrode is 14 μm in diameter, and 
return electrodes are 9 μm wide. (c) Similar array with pillar electrodes. (d) Image of a single pillar electrode with 
a SIROF-coated cap. The pillar is 10 μm in height, with a cap width of 14 μm and stem width of 10 μm.  
Figure 3. Visually evoked potentials (VEP) and stimulation thresholds. (a) Example VEP waveforms with flat and 
pillar 55 m implants at various irradiances and pulse durations. The traces were averaged over 500 trials. The 
double-headed arrow indicates the primary peak located at ~17 ms post stimulus. The purple arrow indicates the 
secondary negative peak that has high irradiance threshold. The green arrows indicate a VEP component that is 
highly sensitive to pulse duration but not irradiance. (b) Variation of the VEP amplitudes with irradiance. Stars 
indicate the lowest irradiance at which p<0.05 (unpaired t-test, n=5 for each implant type). Thresholds are 
summarized in Table 1. (c) Variation of the VEP amplitude with pulse width. Stars indicate the shortest duration 
at which p<0.05 (same as (b)). Thresholds are summarized in Table 2. (d) Variation of the VEP amplitude with 
frequency for all 4 implant types and for normal vision (n=5). For the plot clarity, we used one-sided error bars 
offset horizontally by the line width in order to avoid overlapping with adjacent bars. All error bars are shown in 
terms of s.e.m. 
Figure 4. Grating acuity. (a) Averaged prosthetic VEP response to alternating gratings with 55 μm pixels (n=5). The 
red dash line indicates the instance of the grating reversal.  (b) Prosthetic and natural VEP amplitude as a function 
of the grating stripe width. Smaller stripe width corresponds to higher grating acuity. Acuity limit, defined as the 
intersection of the fitting line with the noise level (horizontal dash lines), is 48±11 μm for prosthetic response, and 
17±5 μm for natural vision. All errors are listed in terms of s.e.m. 
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